PMC:7094172 / 3940-4123 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T69","span":{"begin":168,"end":172},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"To this end, we considered the binding scores and hydrophobic complementarity of the acquired poses, and further selected the potential leads P1–P3 from Acros and ZINC drug databases."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T25","span":{"begin":142,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0008285"}],"text":"To this end, we considered the binding scores and hydrophobic complementarity of the acquired poses, and further selected the potential leads P1–P3 from Acros and ZINC drug databases."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T46","span":{"begin":142,"end":144},"obj":"Chemical"},{"id":"T47","span":{"begin":168,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_60949"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"To this end, we considered the binding scores and hydrophobic complementarity of the acquired poses, and further selected the potential leads P1–P3 from Acros and ZINC drug databases."}

{"project":"LitCovid-sentences","denotations":[{"id":"T24","span":{"begin":0,"end":183},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To this end, we considered the binding scores and hydrophobic complementarity of the acquired poses, and further selected the potential leads P1–P3 from Acros and ZINC drug databases."}

{"project":"LitCovid-PubTator","denotations":[{"id":"79","span":{"begin":142,"end":147},"obj":"Chemical"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To this end, we considered the binding scores and hydrophobic complementarity of the acquired poses, and further selected the potential leads P1–P3 from Acros and ZINC drug databases."}